License our industry-leading legal content to extend your thought leadership and build your brand.
It took a global pandemic to advance new document review models into wider acceptance. Now —as clients and providers alike realize the efficiencies—remote discovery and document review are here to stay.
Misinformation about which drugs worked and which did not at the outset of the pandemic complicated the lives of compliance chiefs at Pfizer and Regeneron Pharmaceuticals Inc. Both Rady Johnson of Pfizer and Beth Holly of Regeneron said their companies made the decision to be completely, even overly, transparent when developing a vaccine and drug to combat COVID-19.
The International Trade Commission's order bans counterfeit BIC lighters from being imported into the U.S., but BIC is going to have to help Customs and Border Protection enforce the order.
Presented by BigVoodoo